Floatz logo

6 assets in Acute Disease

Therapeutic assets addressing Acute Disease, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Tenecteplase
Acute Disease
ProMedica Health SystemP2/3B (57)
Azacitidine
Acute Disease
Molecular Partners AGP1/2CCC (48)
MP0533
Acute Disease
Molecular Partners AGP1/2CCC (48)
Obinutuzumab
Acute Disease
Molecular Partners AGP1/2CCC (48)
Venetoclax
Acute Disease
Molecular Partners AGP1/2CCC (48)
Gamma-Delta (??) T Cells
Acute Disease
Guangzhou Bio-gene Technology Co., LtdEarly P1C (38)